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INTRODUCTION
Nail-patella syndrome (NPS; OMIM #161200) is an auto-
somal dominant disorder characterized by classic clinical tetrad
of dysplastic finger nails, absent or hypoplastic patellae, elbow
dysplasia, and exostoses (“horns”) of the ilia (1). In addition,
some patients manifest nephropathy and adult-onset glau-
coma (2, 3). The incidence of NPS is estimated at 1 in 50,
000 live births (4). NPS is highly penetrant, but the pheno-
types show marked inter- and intrafamilial variability (4).
NPS is caused by loss-of-function mutations in the LMX1B
gene, which encodes a LIM-homeodomain transcription fac-
tor (5, 6). Animal studies have shown that the LMX1B gene
plays an important role in dorsal-ventral patterning of limb
development, morphogenesis and function of glomerular base-
ment membrane (GBM) and podocyte, as well as in devel-
opment of anterior segment of the eye (7-9). To date, more
than 140 mutations of the LMX1B gene associated with NPS
have been identified (The Human Gene Mutation Database
at the Institute of Medical Genetics in Cardiff http://www.
hgmd.cf.ac.uk/ac/index.php).
This study was conducted to evaluate the clinical manifes-
tations of 9 unrelated Korean children with NPS and 6 of their
affected parents, to investigate mutations of the LMX1B gene,
and to analyze the phenotype-genotype correlation.
MATERIALS AND METHODS
Nine unrelated Korean children, who were clinically diag-
nosed with NPS by the Department of Pediatrics or the De-
partment of Pediatric Orthopedic Surgery at Seoul National
University Children’s Hospital were enrolled in this study. A
pediatric orthopedic surgeon evaluated skeletal abnormalities
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Clinico-Genetic Study of Nail-Patella Syndrome
Nail-patella syndrome (NPS) is an autosomal dominant disease that typically
involves the nails, knees, elbows and the presence of iliac horns. In addition, some
patients develop glomerulopathy or adult-onset glaucoma. NPS is caused by loss-
of-function mutations in the LMX1B gene. In this study, phenotype-genotype corre-
lation was analyzed in 9 unrelated Korean children with NPS and their affected fami-
ly members. The probands included 5 boy and 4 girls who were confirmed to have
NPS, as well as 6 of their affected parents. All of the patients (100%) had dysplas-
tic nails, while 13 patients (86.7%) had patellar anomalies, 8 (53.3%) had iliac horns,
6 (40.0%) had elbow contracture, and 4 (26.7%) had nephropathy including one
patient who developed end-stage renal disease at age 4.2. The genetic study revealed
8 different LMX1B mutations (5 missense mutations, 1 frame-shifting deletion and
2 abnormal splicing mutations), 6 of which were novel. Genotype-phenotype cor-
relation was not identified, but inter- and intrafamilial phenotypic variability was ob-
served. Overall, these findings are similar to the results of previously conducted stud-
ies, and the mechanism underlying the phenotypic variations and predisposing fac-
tors of the development and progression of nephropathy in NPS patients are still
unknown.
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of the patients by physical examination and radiologic stud-
ies. The presence of glaucoma in the adult family members
of the patients was evaluated based only on a review of the
patient history. 
Mutational analysis of the LMX1B gene was conducted for
all 9 patients, and their available family members. Genomic
DNA was prepared from peripheral blood nucleated cells. The
8 coding exons of the LMX1B gene were then amplified by
polymerase chain reaction (PCR) and directly sequenced. The
sequences of the PCR primers are shown in Table 1.
A recent study revealed that the coding sequence of the
human LMX1B gene is longer than previously reported, and
that it includes an additional 23 amino acids at the N-ter-
minus; therefore, the numbering of the LMX1B mutations
has been adjusted (10). However, in our study, the older num-
bering system was used to make the comparison with previ-
ously reported mutations easier.
This study was approved by the Ethics Committee of Seoul
National University Hospital, Seoul, Korea, and informed
consent for the genetic analysis was obtained from all patients
and/or their parents.
RESULTS
The probands included 5 boy and 4 girls with a median
age at the time of clinical diagnosis with NPS of 6.8 yr (range
1.2-13.6 yr). The presenting manifestations included symp-
toms associated with knee abnormalities (habitual patellar dis-
location, pain, locking or clicking) in 6 patients, elbow con-
tracture in 1 patient, nail hypoplasia in 1 patient, and gen-
eralized edema/nephrotic syndrome in 1 patient.
The phenotypes and genotypes of the patients and their
affected family members are summarized in Table 2. Analy-
sis of the LMX1B gene revealed 8 different mutations, includ-
ing 5 missense mutations, 1 frame-shifting deletion (c.680delA)
and 2 abnormal splicing mutations (IVS1-1 G>C and IVS1+
5A>G). Two of the missense mutations were located in the
LIM-B domain of LMX1B (p.His114Gln and p.Leu127Pro),
and 3 were located in the homeodomain (p.Arg200Gln, p.Arg
200Trp and p.Ala213Pro). The p.Arg200Gln mutation was
found in 2 unrelated patients. Three novel missense muta-
tions (p.H114Q, p.L127P and p.R200W) that were identi-
fied in the probands were not detected in 100 control Kore-
an subjects (200 alleles). In 6 of the families, one of the par-
ents was affected both clinically and genetically; however, no
Exon Sense primer Antisense primer
15 ′ -TGACAAGCAGGTGACAGAGGA-3′ 5′ -CTGGCGATCACTCCAGGAGT-3′
25 ′ -CCGAGGACTGGGACGGACTA-3′ 5′ -CTCTCGGAACCCTTGGAGCT-3′
35 ′ -CTCTAGGCAGGATGCCAGCA-3′ 5′ -CCATCTGTGTGCAGCTCAGGT-3′
4+5+6 5′ -CCACGGCAGGTGTCAACAGA-3′ 5′ -GATGGCCTTGGTGGAAGGCT-3′
7+8 5′ -CTGAGCCTGGAGGAGGAGCT-3′ 5′ -CTGTGCCCATCTACCGGTCT-3′
Table 1. Primer sequences used for polymerase chain reaction
No. of
Mutations
Location of Probands/ Nail Patella Elbow Iliac Renal
family mutations Parents dysplasia anomaly anomaly horns disease
1 p.R200Q HD Daughter (+) (+) (+) (+) ESRD
Mother (+) (+) (+) (-) ESRD
2 p.H114Q* LIM-B Daughter (+) (+) (-)( -) PU/mHU
Father (+) (+) (-)( -) ESRD
3 p.L127P* LIM-B Son (+) (+) (-)( -)( -)
Mother (+) (-)( -)( -)( -)
4 p.A213P HD Son (+) (+) (+) (-)( -)
5 p.R200W* HD Son (+) (+) (-)( -)( -)
6 c.680delA* HD Daughter (+) (+) (+) (+) (-)
Father (+) (+) (+) (+) (-)
7 p.R200Q HD  Son (+) (+) (+) (+) (-)
Mother (+)
� (-) (-)( -)( -)
8 IVS1-1G>C* Son (+) (+) (-)( + )( -)
Mother (+) (+) (-)( + )( -)
9 IVS1+5A>G* Daughter (+) (+) (-)( + )( -)
Frequency 15/15 13/15 6/15 7/15 4/15
% 100% 87% 40% 47% 27%
*novel mutations; 
� The only phenotype observed in this patient was the absence of skin creases overlying the distal interphalangeal joints.
ESRD, end-stage renal disease; PU/mHU, proteinuria and microscopic hematuria; HD, homeodomain; LIM-B, LIM-B domain.
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siblings in any of the families were affected. Two of the patients
(families 5 and 9 in Table 2) were confirmed to have a de novo
mutation. Finally, the patient in family 4 was an adopted son;
therefore, his family history was unavailable.
The clinical features were analyzed in 9 index cases and 6
affected parents. All patients and affected parents were found
to have dysplastic thumb nails with/without the involvement
of other finger nails. In addition, dysplastic toe nails were detect-
ed in 10 patients. Patellar anomalies were noted in all index
cases and 4 of the affected parents. These anomalies includ-
ed aplasia in 2 patients and hypoplasia in 11. Elbow contrac-
tures (cubitus valgus) with/without radial head dislocation
were detected in 4 patients and 2 parents, and iliac horns were
detected in 5 patients and 3 parents. 
Renal involvement was detected in 2 patients and their
affected parents (families 1 and 2 in Table 2). In the case of
the patient in family 1, the renal involvement presented as
full-blown nephrotic syndrome at the age of 2.2 yr, which
did not respond to conventional oral steroid treatment and
progressed to end-stage renal disease within 2 yr. A renal
biopsy performed when she was 2.5 yr old revealed focal seg-
mental glomerulosclerosis (segmental sclerosis and global scle-
rosis in 56% and 28% of the glomeruli, respectively). How-
ever, electron microscopic examination was unavailable due
to lack of glomeruli in the specimen. Her mother had suffered
from asymptomatic proteinuria since the age of 18, and had
progressed to end-stage renal disease at age 28. She had also
developed vestibular Schwannoma at age 26. The patient in
family 2 was diagnosed with NPS at age 6, at which time
mild proteinuria and microscopic hematuria were detected.
Renal disease in this patient was stable until the follow-up,
which occurred at age 9. Her father, who had same mutation
and clinical features, developed end-stage renal disease and
underwent renal transplantation at age 35.
Glaucoma or hearing difficulty was not detected in any pa-
tients or affected family members.
The range and severity of the clinical manifestations dif-
fered between and within families. For an extreme example,
while the patient in family 7 had the phenotype for the entire
clinical tetrad, the only phenotype shown by his mother was
the absence of skin creases overlying the distal interphalangeal
(DIP) joints.
DISCUSSION
NPS is caused by heterozygous loss-of-function mutations
of the LMX1B gene, which encodes LMX1B, a member of
the LIM-homeodomain family of transcription factors (11)
LMX1B contains two cystine-rich zinc-binding motifs (LIM-
A and LIM-B domain), a homeodomain, and a carboxy ter-
minal glutamine-rich and serine-rich domain. LIM domains
are involved in interactions with other transcription factors
and synergistic activation of transcription. The homeodomain
is involved in DNA binding, and the carboxy terminal domain
represents a transcriptional activation domain (12, 13). To
date, 142 LMX1B mutations have been identified and deposit-
ed in the Human Gene Mutation Database at the Institute
of Medical Genetics in Cardiff (http://www.hgmd.cf.ac.uk/
ac/index.php). These include 80 missense/nonsense muta-
tions and 16 abnormal splicing mutations. Among these 80
missense/nonsense mutations, 31 (38.8%) are located in the
LIM-A domain, 15 (18.8%) in the LIM-B domain, and 30
(37.5%) in the homeodomain. In our study, no mutations
were detected in the LIM-A domain. 
LMX1B is required for a wide range of developmental pro-
cesses including dorso-ventral patterning of the limb, differ-
entiation of dopaminergic and serotonergic neurons, pattern-
ing of the skull, and normal development of the kidney and
eye (1, 5, 7, 9, 14). Accordingly, NPS shows variable pheno-
type with multi-organ involvement. Besides the classic clin-
ical tetrad (dysplasia of the patellae, nails and elbows and the
presence of iliac horns), other components of the musculoskele-
tal system such as muscle, tendons, and ligaments can be affect-
ed. In addition, other organs such as kidneys, eyes and pos-
sibly ears, the nervous system and the gastrointestinal tract
can be affected as part of the syndrome (1, 4). Although NPS
is a highly penetrant hereditary disorder, it shows marked
inter- and intrafamilial phenotypic variability (4). In this study,
autosomal dominant inheritance was confirmed both pheno-
typically and genetically in 7 of the 9 families, while the re-
maining two patients had de novo mutations. In addition,
although we did not identify a genotype-phenotype correla-
tion, we did observe inter- and intrafamilial phenotypic vari-
ability.
Changes in the nails, which were detected in all of the pati-
ents in this study, are the most constant clinical features of
NPS and are detected in almost all patients. These features
may include the development of only the triangular lunulae,
which is one of the pathognomonic signs of NPS (15). Anoth-
er common and sensitive sign of digital involvement is loss
of DIP skin creases (4), which was the only abnormality detect-
ed in mother of Patient 7 in this study. Knee involvement
including typical patellar hypoplasia or aplasia is also very
common, and 6 of 9 patients in this study visited the hospi-
tal due to symptoms associated with their knee joints. Elbow
abnormalities including limitation of joint motion, hypopla-
sia of the radial head, and subluxation or dislocation of the
radial heads can also occur with/without antecubital ptery-
gia. Iliac horns are bilateral and conical bony processes that
project postero-laterally from the central part of the iliac bones,
are considered pathognomonic of NPS. A previously conduct-
ed review of NPS reported the following frequencies of symp-
toms associated with the disease: nail anomalies 95.1%, patel-
lar involvement 92.7%, elbow dysplasia 92.5%, and iliac horns
70-80% (15). Additionally, a British study of 123 NPS patients
from 43 families reported that nail changes were detected in
98% of the patients, knee symptoms in 74% of the patients,Clinico-Genetic Study of Nail-Patella Syndrome S85
elbow symptoms in 33% of the patients, and iliac horns in
68% of the patients (4). The frequencies of the abnormali-
ties observed in our study were similar to those observed in
the British study. 
The incidence of renal involvement in patients with NPS
has been reported to be 12-62% (4, 16), which is compara-
ble to the results observed in the present study (27%). The
earliest sign of renal involvement in NPS is proteinuria with
or without hematuria, which may remit spontaneously or
progress to overt nephritis. Approximately 5-15% of all patients
develop chronic renal failure (4, 16). Thus, renal involvement
is one of the major prognostic factors of NPS. In spite of this,
the factors responsible for the development and progression
of nephropathy in patients with NPS are largely unknown.
However, a recent study drew the following conclusions regard-
ing renal involvement in patients with NPS: 1) quantitative
urinalysis revealed the presence of proteinuria in 21.3% of
the patients, and microalbuminuria was detected in 21.7%
of the patients without overt proteinuria, 2) proteinuria and
microalbuminuria were found to occur significantly more
frequently in females, 3) patients with an LMX1B mutation
located in the homeodomain were found to have a significant-
ly greater occurrence and higher values of proteinuria than
those carrying mutations in the LIM domains, and 4) a pos-
itive family history of nephropathy and presence of radial
head hypoplasia were found to be associated with an increased
individual risk of developing renal disease (17). In our study,
renal involvement was detected in 2 patients and their affect-
ed parents, 3 of whom were females. However, mutation locat-
ed in the homeodomain and radial head hypoplasia were detect-
ed in only one of the families.
The most common renal pathologic findings characteris-
tic of NPS are focal or diffuse and irregular thickening of the
GBM with patchy electron-lucent areas (so called ‘moth-eaten’
appearance) and irregular deposition of bundles of fibrillar
collagen (type III collagen) within the GBM and the mesan-
gial matrix. These characteristic ultrastructural features of the
GBM have been observed in all biopsied NPS patients. How-
ever, the severity of these changes do not correlate well with
patient’s age, the severity of proteinuria, the degree of impaired
renal function, or even the presence of nephropathy (15, 16,
18-20). In our study, renal biopsy was performed in only one
patient (family 1) who had developed full-blown nephrotic
syndrome at the age of 2.2 yr and end-stage renal disease at
age 4. Her clinical course was rather unusual because the pro-
gression to end-stage renal disease in patients with NPS is
usually slow (15, 16). Her renal biopsy, which was performed
at age 2.5, revealed focal segmental glomerulosclerosis. How-
ever, the GBM changes were not evaluated due to lack of gl-
omeruli in the specimen. 
Open angle glaucoma or ocular hypertension is a recently
recognized phenotype of NPS (4, 6, 21). These lesions, which
usually develop during adulthood, are treatable; therefore,
regular ophthalmologic screening of patients with NPS should
be strongly encouraged. In our study, no patients or adult
family members with glaucoma were detected, but its pres-
ence was evaluated solely based on patient history.
In conclusion, the phenotypic and genotypic features of the
patients evaluated in this study were similar to those observed
in previously conducted studies. In addition, inter- and intrafa-
milial variability of the phenotypes was observed, but no geno-
type-phenotype correlation was observed. However, the mech-
anism underlying the phenotypic variations and predispos-
ing factors of the development and progression of nephropa-
thy in NPS patients are still unknown. 
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